250 related articles for article (PubMed ID: 11583747)
1. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial.
TIME Investigators
Lancet; 2001 Sep; 358(9286):951-7. PubMed ID: 11583747
[TBL] [Abstract][Full Text] [Related]
2. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants.
Lancet; 1997 Aug; 350(9076):461-8. PubMed ID: 9274581
[TBL] [Abstract][Full Text] [Related]
3. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial.
Pfisterer M; Buser P; Osswald S; Allemann U; Amann W; Angehrn W; Eeckhout E; Erne P; Estlinbaum W; Kuster G; Moccetti T; Naegeli B; Rickenbacher P;
JAMA; 2003 Mar; 289(9):1117-23. PubMed ID: 12622581
[TBL] [Abstract][Full Text] [Related]
4. Revascularization led to less angina and fewer adverse cardiac events than did optimal medical care in angina pectoris in the elderly.
Walker JM
ACP J Club; 2002; 137(1):A-16; author reply A-16. PubMed ID: 12093238
[No Abstract] [Full Text] [Related]
5. Early invasive strategy in elderly patients with non-ST elevation acute coronary syndrome: comparison with younger patients regarding 30 day and long term outcome.
Liistro F; Angioli P; Falsini G; Ducci K; Baldassarre S; Burali A; Bolognese L
Heart; 2005 Oct; 91(10):1284-8. PubMed ID: 15761051
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME).
Pfisterer M;
Circulation; 2004 Sep; 110(10):1213-8. PubMed ID: 15337691
[TBL] [Abstract][Full Text] [Related]
7. Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery disease.
Bonetti PO; Kaiser C; Zellweger MJ; Grize L; Erne P; Schoenenberger RA; Pfisterer ME;
J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):29-37. PubMed ID: 15821836
[TBL] [Abstract][Full Text] [Related]
8. Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trial.
Kaiser C; Kuster GM; Erne P; Amann W; Naegeli B; Osswald S; Buser P; Schläpfer H; Brett W; Zerkowski HR; Schindler C; Pfisterer M;
Eur Heart J; 2004 Jun; 25(12):1036-42. PubMed ID: 15191774
[TBL] [Abstract][Full Text] [Related]
9. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses.
Hueb WA; Bellotti G; de Oliveira SA; Arie S; de Albuquerque CP; Jatene AD; Pileggi F
J Am Coll Cardiol; 1995 Dec; 26(7):1600-5. PubMed ID: 7594092
[TBL] [Abstract][Full Text] [Related]
10. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.
Wallentin L; Lagerqvist B; Husted S; Kontny F; Ståhle E; Swahn E
Lancet; 2000 Jul; 356(9223):9-16. PubMed ID: 10892758
[TBL] [Abstract][Full Text] [Related]
11. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study.
Lagerqvist B; Husted S; Kontny F; Ståhle E; Swahn E; Wallentin L;
Lancet; 2006 Sep; 368(9540):998-1004. PubMed ID: 16980115
[TBL] [Abstract][Full Text] [Related]
12. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators.
Lancet; 1999 Aug; 354(9180):708-15. PubMed ID: 10475181
[TBL] [Abstract][Full Text] [Related]
13. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina.
Fox KA; Poole-Wilson PA; Henderson RA; Clayton TC; Chamberlain DA; Shaw TR; Wheatley DJ; Pocock SJ;
Lancet; 2002 Sep; 360(9335):743-51. PubMed ID: 12241831
[TBL] [Abstract][Full Text] [Related]
14. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial.
Fox KA; Poole-Wilson P; Clayton TC; Henderson RA; Shaw TR; Wheatley DJ; Knight R; Pocock SJ
Lancet; 2005 Sep 10-16; 366(9489):914-20. PubMed ID: 16154018
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME).
Claude J; Schindler C; Kuster GM; Schwenkglenks M; Szucs T; Buser P; Osswald S; Kaiser C; Grädel C; Estlinbaum W; Rickenbacher P; Pfisterer M;
Eur Heart J; 2004 Dec; 25(24):2195-203. PubMed ID: 15589636
[TBL] [Abstract][Full Text] [Related]
16. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
[TBL] [Abstract][Full Text] [Related]
17. Improvements in physical and mental domains of quality of life by anti-ischaemic drug and revascularisation treatment in elderly men and women with chronic angina.
Buser MA; Buser PT; Kuster GM; Grize L; Pfisterer M;
Heart; 2008 Nov; 94(11):1413-8. PubMed ID: 18208833
[TBL] [Abstract][Full Text] [Related]
18. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.
Thiele H; Zeymer U; Neumann FJ; Ferenc M; Olbrich HG; Hausleiter J; de Waha A; Richardt G; Hennersdorf M; Empen K; Fuernau G; Desch S; Eitel I; Hambrecht R; Lauer B; Böhm M; Ebelt H; Schneider S; Werdan K; Schuler G;
Lancet; 2013 Nov; 382(9905):1638-45. PubMed ID: 24011548
[TBL] [Abstract][Full Text] [Related]
19. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
[TBL] [Abstract][Full Text] [Related]
20. [Quality of life and working status in patients with coronary artery disease treated by percutaneous coronary angioplasty during long-term observation].
Przewłocki T; Syty M; Ryniewicz W; Piatek J; Podolec P; Lelakowski J; Pieniazek P; Tracz W
Przegl Lek; 2000; 57(12):691-8. PubMed ID: 11398588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
